UWM
MIST icon

Urban Wealth Management’s Milestone Pharmaceuticals MIST Stock Holding History

Urban Wealth Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$20K Buy
+3,194
New +$19.6K 0.07% 146

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Urban Wealth Management's MIST Position: Q2 2022 in Review

Urban Wealth Management opened a new position in Milestone Pharmaceuticals (MIST) in Q2 2022: 3,194 shares worth $20K. The stake represents 0.07% of the portfolio and ranks #146 among its holdings.

29 funds tracked by Wall St. Rank hold MIST as of Q2 2022.

  • Urban Wealth Management held 3,194 shares of Milestone Pharmaceuticals worth $20K as of Q2 2022.
  • Milestone Pharmaceuticals was a new Urban Wealth Management position in Q2 2022.
  • Milestone Pharmaceuticals made up 0.07% of Urban Wealth Management's portfolio in Q2 2022, its #146 holding.
  • 29 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2022.

Based on Urban Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.